Depressive symptoms exacerbate disability in older adults: A prospective cohort analysis of participants in the MemAID trial is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: NIDDK-1R01DK103902-5
Harvard Catalyst - The Harvard Clinical and Translational Science Center
Grant: National Center for Advancing Translational Sciences, National Institutes of Health Award UL 1TR002541
Novo-Nordisk Inc.; Bagsværd, Denmark
Grant: ISS-001063
Medtronic Inc., Northridge CA, USA
Grant: NERP15-031
National Institutes of Health
Grant: 1K23AG068384-01A1
Sidney R. Baer Jr. Foundation
Grant: 01028951
Alzheimer’s Association
Grant: 2019-AACSF-643094
NeuroNEXT
Grant: U24NS107183
NIA NIH HHS
Grant: K23 AG068364
EPA
Grant: EP-C-15-031
NIDDK NIH HHS
Grant: R01 DK103902
National Institutes of Health
Grant: 5UL1TR002541-04
The Harvard Clinical and Translational Science Center
National Institutes of Health
Grant: 5U24NS107183-05
Boston Children's Hospital and Beth Israel Deaconess Medical Center NeuroNEXT Clinical Research Site
National Institutes of Health
Grant: 1R01DK103902-01A1
Memory Advancement by Intranasal Insulin in Type 2 Diabetes (MemAID)
Harvard University
FWCI
0.63
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals